KIM
DMII

Karpus Investment Management’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Karpus Investment Management’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$25.9M Buy
2,597,923
+1,454,298
+127% +$14.5M 0.81% 27
2025
Q4 		$11.3M Buy
+1,143,625
New +$11.3M 0.35% 75

Other funds holding DMII

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Karpus Investment Management's DMII Position: Q1 2026 in Review

Karpus Investment Management increased its Drugs Made In America Acquisition II Corp (DMII) stake by 127% in Q1 2026, buying an estimated $14.5M and bringing the position to 2,597,923 shares worth $25.9M. The position accounts for 0.81% of the portfolio, ranked #27.

Karpus Investment Management first reported a position in DMII in Q4 2025 and has held it in 2 quarters since. 68 funds tracked by Wall St. Rank hold DMII as of Q1 2026.

  • Karpus Investment Management held 2,597,923 shares of Drugs Made In America Acquisition II Corp worth $25.9M as of Q1 2026.
  • Karpus Investment Management bought 1,454,298 Drugs Made In America Acquisition II Corp shares in Q1 2026, an estimated $14.5M.
  • Drugs Made In America Acquisition II Corp made up 0.81% of Karpus Investment Management's portfolio in Q1 2026, its #27 holding.
  • Karpus Investment Management first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 2 quarters since.
  • 68 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q1 2026.

Based on Karpus Investment Management's 13F filing for Q1 2026, filed 14 May 2026.